Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Filana Therapeutics, Inc. - Common Stock (NQ:FLNA)

0.9650 +0.0790 (+8.92%)
Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,791,773
Open 1.000
Bid (Size) 0.9586 (1,600)
Ask (Size) 0.9774 (6,000)
Prev. Close 0.8860
Today's Range 0.9300 - 1.030
52wk Range 0.6701 - 2.267
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are moving in today's after hours session ↗
Via Chartmill
Unusual volume stocks in Wednesday's session ↗
Via Chartmill

Performance

YTD
-53.8%
-53.8%
1 Month
+7.5%
+7.5%
3 Month
-22.8%
-22.8%
6 Month
-43.9%
-43.9%
1 Year
-53.8%
-53.8%

More News

Read More
Gapping stocks in Wednesday's session ↗
Via Chartmill
These stocks are moving in today's after hours session ↗
Via Chartmill
Which stocks are experiencing notable movement on Tuesday? ↗
Via Chartmill
Which stocks are most active on Tuesday? ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Gapping stocks in Tuesday's session ↗
Via Chartmill
News headline image
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
From Filana Therapeutics, Inc.
Via GlobeNewswire
News headline image
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
From Filana Therapeutics, Inc.
Via GlobeNewswire
News headline image
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
From Filana Therapeutics, Inc.
Via GlobeNewswire
News headline image
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
From Filana Therapeutics, Inc.
Via GlobeNewswire
News headline image
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
From Filana Therapeutics, Inc.
Via GlobeNewswire
News headline image
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
From Filana Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Filana Therapeutics, Inc. - Common Stock publicly traded?
Yes, Filana Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Filana Therapeutics, Inc. - Common Stock trade on?
Filana Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Filana Therapeutics, Inc. - Common Stock?
The ticker symbol for Filana Therapeutics, Inc. - Common Stock is FLNA on the Nasdaq Stock Market
What is the current price of Filana Therapeutics, Inc. - Common Stock?
The current price of Filana Therapeutics, Inc. - Common Stock is 0.9650
When was Filana Therapeutics, Inc. - Common Stock last traded?
The last trade of Filana Therapeutics, Inc. - Common Stock was at 10/01/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.